Cleared Traditional

K200325 - Orbit Subretinal Delivery System (FDA 510(k) Clearance)

Jul 2020
Decision
155d
Days
Class 2
Risk

K200325 is an FDA 510(k) clearance for the Orbit Subretinal Delivery System. This device is classified as a Syringe, Piston (Class II - Special Controls, product code FMF).

Submitted by Orbit Biomedical (Ambler, US). The FDA issued a Cleared decision on July 14, 2020, 155 days after receiving the submission on February 10, 2020.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K200325 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 2020
Decision Date July 14, 2020
Days to Decision 155 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code FMF - Syringe, Piston
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860

Similar Devices - FMF Syringe, Piston

All 28
Profoject™ Insulin Syringes
K253068 · CMT Health PTE., Ltd. · Feb 2026
Instylla Delivery Kit
K253769 · Instylla, Inc. · Dec 2025
DuoprossTM Smart Cap (Type I)
K252518 · Duopross Meditech Corporate · Dec 2025
EXEL Disposable Syringe
K251089 · Exelint International, Co. · Dec 2025
Verisafe Safety Retractable Insulin Syringes
K250192 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2025
Merit Syringe
K250853 · Merit Medical Systems, Inc. · Nov 2025